BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31104904)

  • 1. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
    Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
    Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
    van Niekerk CC; van Dijck JAAM; Verbeek ALM
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
    Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between uterine serous carcinoma and breast cancer.
    Gehrig PA; Bae-Jump VL; Boggess JF; Groben PA; Fowler WC; Van Le L
    Gynecol Oncol; 2004 Jul; 94(1):208-11. PubMed ID: 15262144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and clinical outcomes of non-endometrioid carcinoma of endometrium: Siriraj Hospital experience.
    Jaishuen A; Kunakornporamat K; Viriyapak B; Benjapibal M; Chaopotong P; Petsuksiri J; Therasakvichya S
    Asian Pac J Cancer Prev; 2014; 15(6):2905-9. PubMed ID: 24761923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of WT1, B-cell lymphoma 2, Ki-67 (Mib1), and Her2/Neu as diagnostic and prognostic immunomarkers in ovarian serous and endometroid carcinoma.
    Mondal SK; Basak B; Bhattacharya S; Panda UK
    J Cancer Res Ther; 2021; 17(1):164-169. PubMed ID: 33723149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.
    Trabert B; Aarestrup J; Ulrich LG; Wentzensen N; Sørensen TIA; Baker JL
    Gynecol Oncol; 2018 Mar; 148(3):547-552. PubMed ID: 29331371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.
    Lee AW; Ness RB; Roman LD; Terry KL; Schildkraut JM; Chang-Claude J; Doherty JA; Menon U; Cramer DW; Gayther SA; Risch H; Gentry-Maharaj A; Goodman MT; Modugno F; Eilber U; Moysich KB; Berchuck A; Rossing MA; Jensen A; Wicklund KG; Cushing-Haugen KL; Hogdall E; Rudolph A; Thompson PJ; Wilkens LR; Kjaer SK; Carney ME; Stram DO; Ramus SJ; Wu AH; Pike MC; Pearce CL;
    Obstet Gynecol; 2016 May; 127(5):828-836. PubMed ID: 27054934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and age at diagnosis of endometrial cancer.
    Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Levitt J; Girda E; Goldfinger M; Goldberg GL; Einstein MH
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):300-306. PubMed ID: 25004350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.
    Prentice RL; Thomson CA; Caan B; Hubbell FA; Anderson GL; Beresford SA; Pettinger M; Lane DS; Lessin L; Yasmeen S; Singh B; Khandekar J; Shikany JM; Satterfield S; Chlebowski RT
    J Natl Cancer Inst; 2007 Oct; 99(20):1534-43. PubMed ID: 17925539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
    Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
    Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma.
    Kamal M; Burmeister C; Zhang Z; Munkarah A; Elshaikh MA
    Anticancer Res; 2015 Jul; 35(7):4053-7. PubMed ID: 26124354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.
    Hemminki K; Aaltonen L; Li X
    Cancer; 2003 May; 97(10):2432-9. PubMed ID: 12733142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial ovarian cancers and endometriosis.
    Acién P; Velasco I; Acién M; Capello C; Vela P
    Gynecol Obstet Invest; 2015; 79(2):126-35. PubMed ID: 25634648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
    Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
    Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
    Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.